Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene-based Therapy Medicinal Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene-based Therapy Medicinal Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene-based Therapy Medicinal Market Perspective (2018-2029)
2.2 Global Gene-based Therapy Medicinal Growth Trends by Region
2.2.1 Gene-based Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene-based Therapy Medicinal Historic Market Size by Region (2018-2024)
2.2.3 Gene-based Therapy Medicinal Forecasted Market Size by Region (2024-2029)
2.3 Gene-based Therapy Medicinal Market Dynamics
2.3.1 Gene-based Therapy Medicinal Industry Trends
2.3.2 Gene-based Therapy Medicinal Market Drivers
2.3.3 Gene-based Therapy Medicinal Market Challenges
2.3.4 Gene-based Therapy Medicinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene-based Therapy Medicinal by Players
3.1.1 Global Gene-based Therapy Medicinal Revenue by Players (2018-2024)
3.1.2 Global Gene-based Therapy Medicinal Revenue Market Share by Players (2018-2024)
3.2 Global Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene-based Therapy Medicinal, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Gene-based Therapy Medicinal Market Concentration Ratio
3.4.1 Global Gene-based Therapy Medicinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene-based Therapy Medicinal Revenue in 2022
3.5 Global Key Players of Gene-based Therapy Medicinal Head office and Area Served
3.6 Global Key Players of Gene-based Therapy Medicinal, Product and Application
3.7 Global Key Players of Gene-based Therapy Medicinal, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene-based Therapy Medicinal Breakdown Data by Type
4.1 Global Gene-based Therapy Medicinal Historic Market Size by Type (2018-2024)
4.2 Global Gene-based Therapy Medicinal Forecasted Market Size by Type (2024-2029)
5 Gene-based Therapy Medicinal Breakdown Data by Application
5.1 Global Gene-based Therapy Medicinal Historic Market Size by Application (2018-2024)
5.2 Global Gene-based Therapy Medicinal Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene-based Therapy Medicinal Market Size (2018-2029)
6.2 North America Gene-based Therapy Medicinal Market Size by Type
6.2.1 North America Gene-based Therapy Medicinal Market Size by Type (2018-2024)
6.2.2 North America Gene-based Therapy Medicinal Market Size by Type (2024-2029)
6.2.3 North America Gene-based Therapy Medicinal Market Share by Type (2018-2029)
6.3 North America Gene-based Therapy Medicinal Market Size by Application
6.3.1 North America Gene-based Therapy Medicinal Market Size by Application (2018-2024)
6.3.2 North America Gene-based Therapy Medicinal Market Size by Application (2024-2029)
6.3.3 North America Gene-based Therapy Medicinal Market Share by Application (2018-2029)
6.4 North America Gene-based Therapy Medicinal Market Size by Country
6.4.1 North America Gene-based Therapy Medicinal Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene-based Therapy Medicinal Market Size by Country (2018-2024)
6.4.3 North America Gene-based Therapy Medicinal Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene-based Therapy Medicinal Market Size (2018-2029)
7.2 Europe Gene-based Therapy Medicinal Market Size by Type
7.2.1 Europe Gene-based Therapy Medicinal Market Size by Type (2018-2024)
7.2.2 Europe Gene-based Therapy Medicinal Market Size by Type (2024-2029)
7.2.3 Europe Gene-based Therapy Medicinal Market Share by Type (2018-2029)
7.3 Europe Gene-based Therapy Medicinal Market Size by Application
7.3.1 Europe Gene-based Therapy Medicinal Market Size by Application (2018-2024)
7.3.2 Europe Gene-based Therapy Medicinal Market Size by Application (2024-2029)
7.3.3 Europe Gene-based Therapy Medicinal Market Share by Application (2018-2029)
7.4 Europe Gene-based Therapy Medicinal Market Size by Country
7.4.1 Europe Gene-based Therapy Medicinal Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene-based Therapy Medicinal Market Size by Country (2018-2024)
7.4.3 Europe Gene-based Therapy Medicinal Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene-based Therapy Medicinal Market Size (2018-2029)
8.2 China Gene-based Therapy Medicinal Market Size by Type
8.2.1 China Gene-based Therapy Medicinal Market Size by Type (2018-2024)
8.2.2 China Gene-based Therapy Medicinal Market Size by Type (2024-2029)
8.2.3 China Gene-based Therapy Medicinal Market Share by Type (2018-2029)
8.3 China Gene-based Therapy Medicinal Market Size by Application
8.3.1 China Gene-based Therapy Medicinal Market Size by Application (2018-2024)
8.3.2 China Gene-based Therapy Medicinal Market Size by Application (2024-2029)
8.3.3 China Gene-based Therapy Medicinal Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene-based Therapy Medicinal Market Size (2018-2029)
9.2 Asia Gene-based Therapy Medicinal Market Size by Type
9.2.1 Asia Gene-based Therapy Medicinal Market Size by Type (2018-2024)
9.2.2 Asia Gene-based Therapy Medicinal Market Size by Type (2024-2029)
9.2.3 Asia Gene-based Therapy Medicinal Market Share by Type (2018-2029)
9.3 Asia Gene-based Therapy Medicinal Market Size by Application
9.3.1 Asia Gene-based Therapy Medicinal Market Size by Application (2018-2024)
9.3.2 Asia Gene-based Therapy Medicinal Market Size by Application (2024-2029)
9.3.3 Asia Gene-based Therapy Medicinal Market Share by Application (2018-2029)
9.4 Asia Gene-based Therapy Medicinal Market Size by Region
9.4.1 Asia Gene-based Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene-based Therapy Medicinal Market Size by Region (2018-2024)
9.4.3 Asia Gene-based Therapy Medicinal Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene-based Therapy Medicinal Introduction
11.1.4 Biogen Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene-based Therapy Medicinal Introduction
11.2.4 Novartis Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene-based Therapy Medicinal Introduction
11.3.4 Gilead Sciences Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene-based Therapy Medicinal Introduction
11.6.4 Amgen Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene-based Therapy Medicinal Introduction
11.7.4 Spark Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Introduction
11.8.4 Akcea Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Details
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech Gene-based Therapy Medicinal Introduction
11.9.4 Sunway Biotech Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.9.5 Sunway Biotech Recent Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Details
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO Gene-based Therapy Medicinal Introduction
11.10.4 SIBIONO Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.10.5 SIBIONO Recent Developments
11.11 AnGes
11.11.1 AnGes Company Details
11.11.2 AnGes Business Overview
11.11.3 AnGes Gene-based Therapy Medicinal Introduction
11.11.4 AnGes Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.11.5 AnGes Recent Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Details
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Introduction
11.12.4 Orchard Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.12.5 Orchard Therapeutics Recent Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Details
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Introduction
11.13.4 Human Stem Cells Institute Revenue in Gene-based Therapy Medicinal Business (2018-2024)
11.13.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene-based Therapy Medicinal Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene-based Therapy Medicinal Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene-based Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene-based Therapy Medicinal Market Share by Region (2018-2024)
Table 8. Global Gene-based Therapy Medicinal Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene-based Therapy Medicinal Market Share by Region (2024-2029)
Table 10. Gene-based Therapy Medicinal Market Trends
Table 11. Gene-based Therapy Medicinal Market Drivers
Table 12. Gene-based Therapy Medicinal Market Challenges
Table 13. Gene-based Therapy Medicinal Market Restraints
Table 14. Global Gene-based Therapy Medicinal Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene-based Therapy Medicinal Revenue Share by Players (2018-2024)
Table 16. Global Top Gene-based Therapy Medicinal by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
Table 17. Global Gene-based Therapy Medicinal Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Gene-based Therapy Medicinal Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Gene-based Therapy Medicinal, Headquarters and Area Served
Table 20. Global Key Players of Gene-based Therapy Medicinal, Product and Application
Table 21. Global Key Players of Gene-based Therapy Medicinal, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2024)
Table 25. Global Gene-based Therapy Medicinal Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene-based Therapy Medicinal Revenue Market Share by Type (2024-2029)
Table 27. Global Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene-based Therapy Medicinal Revenue Share by Application (2018-2024)
Table 29. Global Gene-based Therapy Medicinal Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene-based Therapy Medicinal Revenue Share by Application (2024-2029)
Table 31. North America Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Gene-based Therapy Medicinal Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Gene-based Therapy Medicinal Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Gene-based Therapy Medicinal Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Gene-based Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Gene-based Therapy Medicinal Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 63. Biogen Company Details
Table 64. Biogen Business Overview
Table 65. Biogen Gene-based Therapy Medicinal Product
Table 66. Biogen Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 67. Biogen Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Gene-based Therapy Medicinal Product
Table 71. Novartis Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Gilead Sciences Company Details
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Gene-based Therapy Medicinal Product
Table 76. Gilead Sciences Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 77. Gilead Sciences Recent Developments
Table 78. Sarepta Therapeutics Company Details
Table 79. Sarepta Therapeutics Business Overview
Table 80. Sarepta Therapeutics Gene-based Therapy Medicinal Product
Table 81. Sarepta Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 82. Sarepta Therapeutics Recent Developments
Table 83. Alnylam Pharmaceuticals Company Details
Table 84. Alnylam Pharmaceuticals Business Overview
Table 85. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product
Table 86. Alnylam Pharmaceuticals Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 87. Alnylam Pharmaceuticals Recent Developments
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Gene-based Therapy Medicinal Product
Table 91. Amgen Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 92. Amgen Recent Developments
Table 93. Spark Therapeutics Company Details
Table 94. Spark Therapeutics Business Overview
Table 95. Spark Therapeutics Gene-based Therapy Medicinal Product
Table 96. Spark Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 97. Spark Therapeutics Recent Developments
Table 98. Akcea Therapeutics Company Details
Table 99. Akcea Therapeutics Business Overview
Table 100. Akcea Therapeutics Gene-based Therapy Medicinal Product
Table 101. Akcea Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 102. Akcea Therapeutics Recent Developments
Table 103. Sunway Biotech Company Details
Table 104. Sunway Biotech Business Overview
Table 105. Sunway Biotech Gene-based Therapy Medicinal Product
Table 106. Sunway Biotech Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 107. Sunway Biotech Recent Developments
Table 108. SIBIONO Company Details
Table 109. SIBIONO Business Overview
Table 110. SIBIONO Gene-based Therapy Medicinal Product
Table 111. SIBIONO Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 112. SIBIONO Recent Developments
Table 113. AnGes Company Details
Table 114. AnGes Business Overview
Table 115. AnGes Gene-based Therapy Medicinal Product
Table 116. AnGes Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 117. AnGes Recent Developments
Table 118. Orchard Therapeutics Company Details
Table 119. Orchard Therapeutics Business Overview
Table 120. Orchard Therapeutics Gene-based Therapy Medicinal Product
Table 121. Orchard Therapeutics Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 122. Orchard Therapeutics Recent Developments
Table 123. Human Stem Cells Institute Company Details
Table 124. Human Stem Cells Institute Business Overview
Table 125. Human Stem Cells Institute Gene-based Therapy Medicinal Product
Table 126. Human Stem Cells Institute Revenue in Gene-based Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 127. Human Stem Cells Institute Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene-based Therapy Medicinal Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene-based Therapy Medicinal Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene-based Therapy Medicinal Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Gene-based Therapy Medicinal Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene-based Therapy Medicinal Report Years Considered
Figure 11. Global Gene-based Therapy Medicinal Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene-based Therapy Medicinal Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene-based Therapy Medicinal Market Share by Region: 2022 VS 2029
Figure 14. Global Gene-based Therapy Medicinal Market Share by Players in 2022
Figure 15. Global Top Gene-based Therapy Medicinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene-based Therapy Medicinal Revenue in 2022
Figure 17. North America Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 19. North America Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 20. North America Gene-based Therapy Medicinal Market Share by Country (2018-2029)
Figure 21. United States Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene-based Therapy Medicinal Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 25. Europe Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 26. Europe Gene-based Therapy Medicinal Market Share by Country (2018-2029)
Figure 27. Germany Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Gene-based Therapy Medicinal Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 35. China Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 36. Asia Gene-based Therapy Medicinal Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 38. Asia Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 39. Asia Gene-based Therapy Medicinal Market Share by Region (2018-2029)
Figure 40. Japan Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Gene-based Therapy Medicinal Market Share by Country (2018-2029)
Figure 50. Brazil Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Gene-based Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Biogen Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 58. Gilead Sciences Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 59. Sarepta Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 61. Amgen Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 62. Spark Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 63. Akcea Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 64. Sunway Biotech Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 65. SIBIONO Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 66. AnGes Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 67. Orchard Therapeutics Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 68. Human Stem Cells Institute Revenue Growth Rate in Gene-based Therapy Medicinal Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed